Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 4/20 | 0.33 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | YWHAZ | P63104 | 3/20 | 0.33 |
| ▸ | ASGR1 | P07306 | 3/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.32 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.32 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12560770 | 0.88 | MAPK1 (0.40) | ALDH1A1PKML3MBTL1KMT2ACA2 | |
| SCHEMBL12560739 | 0.84 | ALDH1A1 (0.37) | ALDH1A1PKML3MBTL1KMT2ACA2 | |
| SCHEMBL8823006 | 0.84 | KMT2A (0.47) | ALDH1A1PKML3MBTL1KMT2ACA2 | |
| SCHEMBL16367194 | 0.84 | KMT2A (0.47) | ALDH1A1PKML3MBTL1KMT2ACA2 | |
| SCHEMBL16864092 | 0.84 | KMT2A (0.47) | ALDH1A1PKML3MBTL1KMT2ACA2 | |
| SCHEMBL2503399 | 0.84 | KMT2A (0.47) | ALDH1A1PKML3MBTL1KMT2ACA2 | |
| SCHEMBL12391259 | 0.84 | KMT2A (0.47) | ALDH1A1PKML3MBTL1KMT2ACA2 | |
| SCHEMBL17231142 | 0.84 | ALDH1A1 (0.49) | ALDH1A1PKML3MBTL1KMT2ATHRB | |
| SCHEMBL16135488 | 0.83 | MAPK1 (0.39) | ALDH1A1PKML3MBTL1KMT2ACA2 | |
| SCHEMBL13129796 | 0.83 | KMT2A (0.37) | ALDH1A1PKML3MBTL1KMT2ACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130243751-A1 | GLYCOCONJUGATES AND THEIR USE AS POTENTIAL VACCINES AGAINST INFECTION BY SHIGELLA FLEXNERI | CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE | 2013-09-19 | — | — | US | disclosed |
| US-8124380-B2 | Oligo/polysaccharides bound to carrier; immunogens; monoclonal antibodies; chimeric antibodies; kits; host cells; transgenic plants/animals | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2012-02-28 | — | — | US | disclosed |
| US-20080112951-A1 | Glycoconjugates and Their Use as Potential Vaccines Against Infection by Shigella Flexneri | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2008-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130243751-A1 | GLYCOCONJUGATES AND THEIR USE AS POTENTIAL VACCINES AGAINST INFECTION BY SHIGELLA FLEXNERI | FUT6, GNE, STT3B | ALDH1A1 3621/4885PKM 4391/4885L3MBTL1 2092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.